A new prodrug offers a new strategy to potentially reduce the recurrence of pancreatic and triple-negative breast cancer in patients who initially respond to treatment.
The majority of national climate adaptation plans fail to fully integrate health needs or engage populations most at risk from climate change, according to a new study.
A circuit that runs from the prefrontal cortex to the insular cortex appears to mediate the antidepressant effects of a newer form of transcranial magnetic stimulation, according to a study led by Weill Cornell Medicine investigators.
Schwartz Research Fund Visionary Grants for faculty members in the life sciences aims to provide significant assistance for innovative, visionary research that opens an important new line of inquiry.
Extreme heat and cold are growing cardiovascular risks that can trigger heart attacks, strokes, heart failure and sudden cardiac death, according to a recent scientific statement by experts at Weill Cornell Medicine and other leading institutions.
A new technology allows scientists to map the DNA-binding sites of transcription factors and other regulatory proteins that control gene activity, according to a study led by Weill Cornell Medicine and the New York Genome Center.
A clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia is an effective alternative to the current standard, which requires repeated hospital or office visits for intravenous treatment.
